Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on September 29, 2026

Sep. 29, 2026

Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

Sep. 29, 2026

Silexion Therapeutics Announces Exercise of Warrants

Indeterminate GlobeNewswire

Sep. 29, 2026

BIO-Europe 2026 to Convene Global Biopharma Decision-Makers in Cologne

Indeterminate GlobeNewswire

Sep. 29, 2026

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

Indeterminate GlobeNewswire

Sep. 29, 2026

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

Indeterminate GlobeNewswire

Sep. 29, 2026

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

Indeterminate GlobeNewswire

Sep. 29, 2026

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Indeterminate GlobeNewswire

Sep. 29, 2026

DiFusion to Define Therapeutic Biomaterials Category at NASS 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Illume Fertility Advances Access to LGBTQ+ Family Building at Men Having Babies New York Annual Conference

Indeterminate GlobeNewswire

Sep. 29, 2026

Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study

Indeterminate GlobeNewswire

Sep. 29, 2026

Weight Watchers and Google Health Enterprise Launch New Collaboration to Enhance Engagement and Outcomes in Weight Health Programs

Indeterminate GlobeNewswire

Sep. 29, 2026

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

Indeterminate GlobeNewswire

Sep. 29, 2026

Noah Medical’s Galaxy System Enters Commercial Use in Asia with First Procedure Completed in Hong Kong

Indeterminate GlobeNewswire

Sep. 29, 2026

Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality

Indeterminate GlobeNewswire

Sep. 29, 2026

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

Indeterminate GlobeNewswire

Sep. 29, 2026

Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Sep. 29, 2026

Claris Bio Announces Oral Presentations at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting and Eyecelerator @ AAO

Indeterminate GlobeNewswire

Sep. 29, 2026

Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development

Indeterminate GlobeNewswire

Sep. 29, 2026

Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer

Indeterminate GlobeNewswire